Our findings link ACOT12-regulated-acetyl-coA metabolic aberration with ICC metastasis and imply that ACOT12 could be a prognostic marker and a potential therapeutic target for ICC metastasis. Here, ACOT12 is linked to intrahepatic cholangiocarcinoma.